ArticleJournal of enzyme inhibition and medicinal chemistry2024

Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases.

Mohamed Elagawany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.